Iranian Journal of Radiology

Published by: Kowsar

Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications

Mahyar Ghafoori 1 , 2 , * , Meysam Velayati 1 , Mounes Aliyari Ghasabeh 2 , Madjid Shakiba 2 and Manijeh Alavi 3
Authors Information
1 Department of Radiology, Hazrat Rasoul Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
2 Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
3 Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, IR Iran
Article information
  • Iranian Journal of Radiology: April 01, 2015, 12 (2); e13257
  • Published Online: April 22, 2015
  • Article Type: Research Article
  • Received: June 27, 2013
  • Accepted: October 3, 2013
  • DOI: 10.5812/iranjradiol.13257

To Cite: Ghafoori M, Velayati M, Aliyari Ghasabeh M, Shakiba M, Alavi M. Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications, Iran J Radiol. 2015 ; 12(2):e13257. doi: 10.5812/iranjradiol.13257.

Copyright © 2015, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomarkers Prev. 1994; 3(2): 105-11[PubMed]
  • 2. Lister S. Urine test could speed treatment of prostate cancer. 2009;
  • 3. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007; 243(1): 28-53[DOI][PubMed]
  • 4. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4): 212-36[DOI][PubMed]
  • 5. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009; 53(2): 171-84[DOI][PubMed]
  • 6. Wang P, Guo YM, Liu M, Qiang YQ, Guo XJ, Zhang YL, et al. A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool. Korean J Radiol. 2008; 9(5): 432-8[DOI][PubMed]
  • 7. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol. 2007; 189(2): 323-8[DOI][PubMed]
  • 8. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010; 341[DOI][PubMed]
  • 9. Tenke P, Horti J, Balint P, Kovacs B. Prostate cancer screening. Recent Results Cancer Res. 2007; 175: 65-81[PubMed]
  • 10. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004; 350(22): 2239-46[DOI][PubMed]
  • 11. Brossner C, Bayer G, Madersbacher S, Kuber W, Klingler C, Pycha A. Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL). BJU Int. 2000; 85(6): 705-7[PubMed]
  • 12. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998; 338(9): 557-63[DOI][PubMed]
  • 13. Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology. 2003; 61(5): 961-6[PubMed]
  • 14. Ito K, Ichinose Y, Kubota Y, Imai K, Yamanaka H. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy. Int J Urol. 1997; 4(5): 474-9[PubMed]
  • 15. Lee SH, Chen SM, Ho CR, Chang PL, Chen CL, Tsui KH. Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer. Chang Gung Med J. 2009; 32(6): 623-7[PubMed]
  • 16. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989; 142(1): 71-4[PubMed]
  • 17. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989; 142(1): 66-70[PubMed]
  • 18. Stamatiou K, Alevizos A, Karanasiou V, Mariolis A, Mihas C, Papathanasiou M, et al. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer. Urol Int. 2007; 78(4): 313-7[DOI][PubMed]
  • 19. Miyake H, Harada K, Inoue TA, Takenaka A, Hara I, Fujisawa M. Additional sampling of dorsal apex on systematic prostate biopsy: impact on early detection of prostate cancer. Urology. 2007; 69(4): 738-42[DOI][PubMed]
  • 20. Guichard G, Larre S, Gallina A, Lazar A, Faucon H, Chemama S, et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol. 2007; 52(2): 430-5[DOI][PubMed]
  • 21. Slongo LE, Sugisawa MC, Ioshii SO, Filho RT, Rocha LC. Efficiency of 6- and 12-punctures biopsies to detect prostate cancer in patients with PSA </= 10 ng/mL and normal digital rectal examination. Int Braz J Urol. 2003; 29(1): 24-9[PubMed]
  • 22. Evidence-based Guidelines for Best Practice in Health Care Transrectal Ultrasound Guided Biopsy of the Prostate. 2011;
  • 23. Saito S. Prostate-specific antigen cut-off point of 2.5 ng/mL and increasing the number of prostate biopsies results in the detection of curable prostate cancer even in Japanese population. Int J Urol. 2007; 14(8): 709-12[DOI][PubMed]
  • 24. Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001; 166(3): 856-60[PubMed]
  • 25. Ecke TH, Gunia S, Bartel P, Hallmann S, Koch S, Ruttloff J. Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire. Urol Oncol. 2008; 26(5): 474-8[DOI][PubMed]
  • 26. Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C. Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol Int. 2010; 84(4): 395-9[DOI][PubMed]
  • 27. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006; 175(5): 1605-12[DOI][PubMed]
  • 28. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998; 159(2): 471-5[PubMed]
  • 29. Egawa S, Matsumoto K, Shitara T, Uchida T, Kuwao S, Koshiba K. Zonal biopsy in the detection of prostate cancer in Japanese men. Jpn J Clin Oncol. 1998; 28(1): 20-6[PubMed]
  • 30. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997; 157(1): 199-202[PubMed]
  • 31. Tobiume M, Yamada Y, Nakamura K, Honda N. Retrospective study comparing six- and twelve-core prostate biopsy in detection of prostate cancer. Int Braz J Urol. 2008; 34(1): 9-14[PubMed]
  • 32. Ghafoori M, Shakiba M, Seifmanesh H, Hoseini K. Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol. 2012; 9(2): 67-70[DOI][PubMed]
  • 33. Thiesler T, Trinkler F, Horcic M, Willi N, Cathomas G, Hailemariam S. Patients with low prostate-specific antigen levels (< or =4 ng/ml) would benefit from a twelve-core biopsy protocol for prostate cancer detection. Urol Int. 2007; 78(4): 318-22[DOI][PubMed]
  • 34. Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol. 2006; 175(2): 485-8[DOI][PubMed]
  • 35. Kojima M, Hayakawa T, Saito T, Mitsuya H, Hayase Y. Transperineal 12-core systematic biopsy in the detection of prostate cancer. Int J Urol. 2001; 8(6): 301-7[PubMed]
  • 36. Matsumoto K, Satoh T, Egawa S, Shimura S, Kuwao S, Baba S. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men. Int J Urol. 2005; 12(4): 353-60[DOI][PubMed]
  • 37. Terris MK, Wallen EM, Stamey TA. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int. 1997; 59(4): 239-42[PubMed]
  • 38. Taylor J3, Gancarczyk KJ, Fant GV, McLeod DG. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer. Urology. 2002; 60(5): 841-5[PubMed]
  • 39. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000; 164(2): 388-92[PubMed]
  • 40. Sugishita K, Harabayashi T, Furuno T, Suzuki S, Shinohara N, Nonomura K. [Transrectal biopsy of the prostate for the detection of non-palpable prostate cancer: a comparison of 6 versus 12 core biopsy]. Nihon Hinyokika Gakkai Zasshi. 2006; 97(6): 782-5[PubMed]
  • 41. Simon J, Kuefer R, Bartsch GJ, Volkmer BG, Hautmann RE, Gottfried HW. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int. 2008; 102(4): 459-62[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments